Authors: Anthony Nicholls
Publish Date: 2016/03/21
Volume: 30, Issue: 4, Pages: 279-280
Abstract
This series inspired by the 2013 Gordon Conference on Computer Aided Drug Design comes to a close this month It has seen a variety of articles each attempting to present aspects of the diverse field of statistics relevant to our discipline the modeling of molecules for drug discovery and improvement There is no doubt that in the wider world even since this series began the provenance of statistics has continued to broaden and deepen As our world becomes ever more connected and datarich the need to understand that data to make sense of it only grows New and successful companies such as Google see the understanding of patterns in vast stores of data as their key aptitude 1 while a venerable one IBM has set a new course guided by the success of its data inference engine Watson 2 There can be no doubt that this trend will engulf drug design as it does the rest of industry What is known as molecular modeling will change just as biochemists become molecular
Keywords: